Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Proper diet management is crucial for phenylketonuria patients to avoid severe health issues.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Three siblings with a genetic form of rickets showed different symptoms of the disease.

Medications for PCOS don't seem to raise heart disease risk.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

A new gene mutation causes insulin resistance in a girl and her mother.